Chloramphenicol molecular imprinting polymer microballoon with uniformity in size as well as preparation method and application thereof
A technology of molecular imprinting and chloramphenicol, applied in alkali metal compounds, chemical instruments and methods, alkali metal oxides/hydroxides, etc., can solve problems such as low adsorption efficiency, poor particle size uniformity, and tailing
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039]First prepare the dispersed phase solution, ultrasonically dissolve 1 mmol of template molecule chloramphenicol in 6 mL of porogen chloroform and ethyl acetate (1:1 by weight), add 4 mmol of functional monomer 4-vinylpyridine, crosslinking agent EDMA 20mmol, initiator azobisisobutyronitrile AIBN 0.18g, the solution was ultrasonically degassed for 5min, nitrogen gas deoxygenated for 15min, then the solution was moved into the syringe of the syringe pump (avoid air entering the syringe as much as possible); the continuous phase solution was Add 0.9 g of dispersant PVA into 60 mL of water, stir to dissolve, ultrasonically degas for 5 min, pass nitrogen gas for deoxygenation for 20 min, and place in a continuous phase container.
[0040] The continuous phase was stirred at 180 rpm and sparged with nitrogen. Driven by the syringe pump, the dispersed phase solution enters the square chamber of the microfluidic device through the connecting tube, and then enters the continuous ...
Embodiment 2
[0044] First prepare the dispersed phase solution, ultrasonically dissolve 1 mmol of the template molecule chloramphenicol in 6 mL of the porogen ethyl acetate, add 3 mmol of the functional monomer 4-vinylpyridine, 30 mmol of the cross-linking agent EDMA, and the initiator azobisisobutyronitrile AIBN 0.15g, the solution was ultrasonically degassed for 5min, nitrogen gas deoxygenated for 15min, and then the solution was moved into the syringe of the syringe pump (try to avoid air entering the syringe); to prepare a continuous phase solution, add dispersant PVA 0.6g to 60mL water, Stir to dissolve, ultrasonically degas for 5 minutes, pass through nitrogen to remove oxygen for 20 minutes, and place in a continuous phase container.
[0045] The continuous phase was stirred at 200 rpm and sparged with nitrogen. Driven by the syringe pump, the dispersed phase solution enters the square chamber of the microfluidic device through the connecting tube, and then enters the continuous pha...
Embodiment 3
[0048] First prepare the dispersed phase solution, ultrasonically dissolve 1 mmol of template molecule chloramphenicol in 5 mL of porogen ethyl acetate, add functional monomer methacrylic acid 2 mmol, crosslinking agent EDMA 20 mmol, initiator azobisisobutyronitrile AIBN 0.20 g, the solution was ultrasonically degassed for 5 minutes, and deoxygenated with nitrogen for 15 minutes, and then moved the solution into the syringe of the syringe pump (try to avoid air entering the syringe); to prepare a continuous phase solution, add 0.6 g of dispersant PVA to 60 mL of water, and stir to dissolve , ultrasonically degassed for 5 minutes, passed through nitrogen to remove oxygen for 20 minutes, and placed in a continuous phase container.
[0049] The continuous phase was stirred at 150 rpm and sparged with nitrogen. Driven by the syringe pump, the dispersed phase solution enters the square chamber of the microfluidic device through the connecting tube, and then enters the continuous ph...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com